Bank of America Corp DE Cuts Holdings in AngioDynamics, Inc. (NASDAQ:ANGO)

Bank of America Corp DE cut its holdings in shares of AngioDynamics, Inc. (NASDAQ:ANGO) by 2.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 67,995 shares of the medical instruments supplier’s stock after selling 1,968 shares during the quarter. Bank of America Corp DE’s holdings in AngioDynamics were worth $623,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in the stock. Rhumbline Advisers raised its position in AngioDynamics by 1.7% in the 4th quarter. Rhumbline Advisers now owns 60,479 shares of the medical instruments supplier’s stock worth $554,000 after purchasing an additional 1,021 shares during the period. Invesco Ltd. grew its stake in shares of AngioDynamics by 1.2% in the 4th quarter. Invesco Ltd. now owns 119,249 shares of the medical instruments supplier’s stock worth $1,092,000 after buying an additional 1,451 shares during the last quarter. OneDigital Investment Advisors LLC grew its position in AngioDynamics by 14.0% during the 4th quarter. OneDigital Investment Advisors LLC now owns 12,137 shares of the medical instruments supplier’s stock valued at $111,000 after purchasing an additional 1,490 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its stake in AngioDynamics by 0.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 329,090 shares of the medical instruments supplier’s stock valued at $3,014,000 after purchasing an additional 2,270 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its holdings in shares of AngioDynamics by 6.9% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 36,936 shares of the medical instruments supplier’s stock valued at $339,000 after acquiring an additional 2,397 shares during the last quarter. Hedge funds and other institutional investors own 89.43% of the company’s stock.

AngioDynamics Stock Up 0.5%

Shares of AngioDynamics stock opened at $11.12 on Tuesday. The stock’s 50-day simple moving average is $9.58 and its 200-day simple moving average is $9.74. AngioDynamics, Inc. has a 52 week low of $5.47 and a 52 week high of $13.50. The company has a market capitalization of $451.55 million, a price-to-earnings ratio of -1.98 and a beta of 0.62.

AngioDynamics (NASDAQ:ANGO) last released its quarterly earnings results on Wednesday, April 2nd. The medical instruments supplier reported $0.03 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.13) by $0.16. AngioDynamics had a negative net margin of 79.38% and a negative return on equity of 7.26%. The company had revenue of $72.00 million for the quarter, compared to the consensus estimate of $70.30 million. The business’s revenue was down 4.3% on a year-over-year basis. On average, equities analysts expect that AngioDynamics, Inc. will post -0.37 earnings per share for the current year.

Analysts Set New Price Targets

Separately, HC Wainwright reissued a “buy” rating and issued a $16.00 target price (up from $15.00) on shares of AngioDynamics in a research report on Monday, April 7th.

AngioDynamics Company Profile

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.